Capital Investment Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Capital Investment Advisory Services's BIIB Position: Q3 2023 in Review
Capital Investment Advisory Services sold out of Biogen (BIIB) in Q3 2023, closing a stake of 747 shares — an estimated $213K sold.
Capital Investment Advisory Services first reported a position in BIIB in Q4 2016 and held it in 16 quarters. The position peaked at $818K in Q4 2016. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.
- Capital Investment Advisory Services reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
- Capital Investment Advisory Services sold 747 Biogen shares in Q3 2023, an estimated $213K.
- Capital Investment Advisory Services first reported a position in Biogen in Q4 2016 and held it in 16 quarters.
- Capital Investment Advisory Services's Biogen position peaked at $818K in Q4 2016.
- 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.
Based on Capital Investment Advisory Services's 13F filing for Q3 2023, filed 2 Nov 2023.